Manulife (Manufacturers Life Insurance)
TVRD

Manulife (Manufacturers Life Insurance)’s Tvardi Therapeutics TVRD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-329
Closed -$10.8K – 3055
2024
Q1 		$10.8K Sell
329
-29
-8% -$752 ﹤0.01% 2938
2023
Q4 		$9.58K Hold
358
– – ﹤0.01% 2952
2023
Q3 		$21.7K Sell
358
-256
-42% -$24K ﹤0.01% 2960
2023
Q2 		$62.6K Buy
614
+120
+24% +$16.5K ﹤0.01% 2940
2023
Q1 		$87.2K Hold
494
– – ﹤0.01% 2772
2022
Q4 		$191K Sell
494
-14
-3% -$5.32K ﹤0.01% 2596
2022
Q3 		$171K Sell
508
-14
-3% -$5.07K ﹤0.01% 2650
2022
Q2 		$171K Sell
522
-10
-2% -$3.51K ﹤0.01% 2726
2022
Q1 		$233K Sell
532
-138
-21% -$56.6K ﹤0.01% 2670
2021
Q4 		$294 Buy
670
+9
+1% +$4.52K ﹤0.01% 2613
2021
Q3 		$367K Sell
661
-60
-8% -$30.1K ﹤0.01% 2515
2021
Q2 		$370K Buy
721
+52
+8% +$33K ﹤0.01% 2647
2021
Q1 		$523K Sell
669
-41
-6% -$28.1K ﹤0.01% 2245
2020
Q4 		$387K Buy
710
+21
+3% +$11K ﹤0.01% 2361
2020
Q3 		$315K Hold
689
– – ﹤0.01% 2258
2020
Q2 		$416K Sell
689
-28
-4% -$15.5K ﹤0.01% 2059
2020
Q1 		$341K Buy
717
+48
+7% +$26.1K ﹤0.01% 2025
2019
Q4 		$388K Buy
669
+6
+0.9% +$4.21K ﹤0.01% 2194
2019
Q3 		$445K Buy
663
+64
+11% +$53.2K ﹤0.01% 2095
2019
Q2 		$464K Buy
599
+262
+78% +$184K ﹤0.01% 2096
2019
Q1 		$238K Buy
337
+46
+16% +$27.5K ﹤0.01% 2340
2018
Q4 		$136K Sell
291
-314
-52% -$203K ﹤0.01% 2400
2018
Q3 		$522K Buy
605
+10
+2% +$7.22K ﹤0.01% 2256
2018
Q2 		$410K Buy
595
+4
+0.7% +$2.03K ﹤0.01% 2551
2018
Q1 		$264K Sell
591
-12
-2% -$5.82K ﹤0.01% 2805
2017
Q4 		$266K Buy
603
+16
+3% +$7.29K ﹤0.01% 2802
2017
Q3 		$290K Sell
587
-4
-0.7% -$2K ﹤0.01% 2684
2017
Q2 		$328K Buy
591
+93
+19% +$59K ﹤0.01% 2625
2017
Q1 		$330K Buy
498
+58
+13% +$31K ﹤0.01% 2478
2016
Q4 		$147K Buy
440
+418
+1,900% +$134K ﹤0.01% 3013
2016
Q3 		$7K Hold
22
– – ﹤0.01% 3796
2016
Q2 		$4K Sell
22
-364
-94% -$79.3K ﹤0.01% 3879
2016
Q1 		$83K Buy
386
+40
+12% +$11.9K ﹤0.01% 3130
2015
Q4 		$210 Hold
346
– – ﹤0.01% 2629
2015
Q3 		$178 Buy
346
+23
+7% +$15.4K ﹤0.01% 2741
2015
Q2 		$142 Buy
323
+262
+430% +$101K ﹤0.01% 3150
2015
Q1 		$22 Hold
61
– – ﹤0.01% 3456
2014
Q4 		$22 Sell
61
-20
-25% -$6.44K ﹤0.01% 3366
2014
Q3 		$24 Buy
81
+37
+84% +$15.2K ﹤0.01% 3417
2014
Q2 		$27K Buy
+44
New +$23.7K ﹤0.01% 3318

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TVRD Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 329 shares — an estimated $10.8K sold.

Manulife (Manufacturers Life Insurance) first reported a position in TVRD in Q2 2014 and held it in 40 quarters. The position peaked at $523K in Q1 2021. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 329 Tvardi Therapeutics shares in Q2 2024, an estimated $10.8K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Tvardi Therapeutics in Q2 2014 and held it in 40 quarters.
  • Manulife (Manufacturers Life Insurance)'s Tvardi Therapeutics position peaked at $523K in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.